Time filter

Source Type

Barcelona, Spain

The Autonomous University of Barcelona also known as UAB is a public university mostly located in Cerdanyola del Vallès, near the city of Barcelona in Catalonia, Spain.As of 2012, it consists of 57 departments in the experimental, life, social and human science, spread among 13 faculties/schools. All these centers together award a total of 85 qualifications in the form of first degrees, diplomas, and engineering degrees. Moreover, almost 80 doctoral programs, and more than 80 other postgraduate programs are offered. UAB has more than 40,000 students and more than 3,600 academic and research staff. The UAB is a pioneering institution in terms of fostering research. There are many research institutes in the campus, as well as other research centers, technical support services and service-providing laboratories. Vila Universitària is the residential complex of the Universitat Autònoma de Barcelona, located on its campus, which has 812 apartments with a total housing capacity for 2193 persons and very good train and bus connections, only 25 minutes away from the centre of Barcelona.The UAB is considered to be the best University in Spain by the 2012 QS World University Rankings, which ranked the university 176th overall in the world. Its subject rankings were: 144th in Life science & Biomedicine, 92th in Arts & Humanities, 106th in Natural science, 95th in Social science and 203rd in Engineering & IT. Wikipedia.

Rurali R.,Autonomous University of Barcelona | Rurali R.,CSIC - Institute of Materials Science
Reviews of Modern Physics | Year: 2010

In this Colloquium the theory of silicon nanowires is reviewed. Nanowires with diameters below 10 nm are the focus, where quantum effects become important and the properties diverge significantly from those of bulk silicon. These wires can be treated within electronic structure simulation methods and will be among the most important functional blocks of future nanoelectronic devices. First, the structural properties of silicon nanowires are reviewed, emphasizing the close connection between the growth orientation, the cross section, and the bounding facets. Second, the electronic structure of pristine and doped nanowires is discussed, which holds the ultimate key for their applicability in novel electronic devices. Finally, transport properties are reviewed where some important limitations in the performances of nanowire-based devices can lay. Many unique properties of these systems are at the same time defying challenges and opportunities for technological advances. © 2010 The American Physical Society. Source

Prat J.,Autonomous University of Barcelona
Annals of Oncology | Year: 2012

Malignant epithelial tumors (carcinomas) are the most common ovarian cancers and also the most lethal gynecological malignancies. Based on histopathology and molecular genetic alterations, ovarian carcinomas are divided into five main types [high-grade serous (70%), endometrioid (10%), clear-cell (10%), mucinous (3%), and low-grade serous carcinomas (<5%)] that account for over 95% of cases. These types are essentially distinct diseases, as indicated by differences in epidemiological and genetic risk factors, precursor lesions, patterns of spread, and molecular events during oncogenesis, response to chemotherapy, and prognosis. For a successful specific treatment, reproducible histopathological diagnosis of the tumor cell type is critical. The five tumor types are morphologically diverse and resemble carcinomas of the uterus. Actually, recent investigations have demonstrated that a substantial number of cancers, traditionally thought to be primary ovarian tumors (particularly serous, endometrioid, and clear-cell carcinomas), originate in the fallopian tube and the endometrium and involve the ovary secondarily. This presentation summarizes recent advances in the molecular pathology which have greatly improved our understanding of the biology of ovarian carcinoma and are also relevant to patient management. © The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. Source

Autonomous University of Barcelona | Date: 2013-07-25

Use of

The present invention relates to a compound of general formula I and to the use thereof as a hapten. An object of the present invention is also a conjugate of said compound I with a carrier protein or fragment thereof, with a detectable labelling agent, or with a polymer or support, and to the use thereof for producing antibodies. Furthermore, the present invention also relates to a method for the detection and/or quantification of 1-hydroxyphenazine and/or pyocyanin using said antibodies and conjugates for the detection of infections caused by

Research Center Biomedica En Red En Bioin Genieria and Autonomous University of Barcelona | Date: 2013-11-15

The present invention relates to the use of inclusion bodies as vehicles for therapeutic protein delivery. This method is applicable to the delivery of therapeutic proteins to intracellular locations. In addition, the invention also relates to the administration of a cell or a pharmaceutical composition comprising inclusion bodies formed by therapeutic proteins. These inclusion bodies formed by therapeutic proteins could be used for the treatment of different diseases.

Discover hidden collaborations